Sale!

CDKL5 Gene Early infantile epileptic encephalopathy type 2 Genetic Test

4,400 د.إ

-21%

The CDKL5 gene early infantile epileptic encephalopathy type 2 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CDKL5 gene. This gene is crucial for normal brain development and function. Mutations in the CDKL5 gene are associated with early infantile epileptic encephalopathy type 2 (EIEE2), a severe neurological condition that manifests in the first few months of life with frequent seizures, developmental delays, and, in some cases, features of autism spectrum disorders. The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the CDKL5 gene. This genetic testing is essential for the accurate diagnosis and management of the condition, allowing for tailored treatment plans and support for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test. This test is designed to diagnose early infantile epileptic encephalopathy type 2 (EIEE2), a rare genetic disorder that affects the brain’s development and causes seizures in infants.

Test Details

The CDKL5 gene is associated with EIEE2, and our NGS (Next-Generation Sequencing) technology allows us to sequence the entire gene and identify any mutations or variations that may be causing this disorder. By conducting this test, we can provide important information for genetic counseling and treatment planning.

Test Components and Price

The CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card. The report will be delivered within 3 to 4 weeks.

Symptoms and Diagnosis

EIEE2 is characterized by seizures that begin in infancy. Other symptoms may include developmental delays, intellectual disability, and movement disorders. Diagnosis of EIEE2 can be confirmed through genetic testing, such as the CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test.

Referring Details

If you are a neurologist referring a patient for the CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test, please provide the patient’s clinical history. Additionally, a genetic counseling session may be necessary to draw a pedigree chart of family members affected by EIEE2.

Test Department and Doctor

The CDKL5 Gene Early Infantile Epileptic Encephalopathy Type 2 Genetic Test falls under the Genetics department. It is recommended to consult with a neurologist for further guidance.

Test Name CDKL5 Gene Early infantile epileptic encephalopathy type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDKL5 Gene Early infantile epileptic encephalopathy type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CDKL5 Gene Early infantile epileptic encephalopathy type 2
Test Details

CDKL5 gene is associated with early infantile epileptic encephalopathy type 2 (EIEE2), a rare genetic disorder that affects the development of the brain and causes seizures starting in infancy. NGS (Next-Generation Sequencing) genetic testing is a method used to sequence the entire CDKL5 gene and identify any mutations or variations that may be causing EIEE2. This test can help diagnose EIEE2 and provide important information for genetic counseling and treatment planning.